News archive

Interview with Hugh Laverty: Executive Director ad interim at Innovative Health Initiative

16/11/22 – Meaningful engagement of the community in TB Research & Development: Best practice initiative from UNITE4TB

25/10/22 – New publication from GNA NOW Consortium published by the American Society for Microbiology

17/10/22 – ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives
https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-09-21 08:14:132023-04-20 10:33:0121/09/22 – ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-09-19 12:21:342023-04-20 10:39:1119/09/22 – UNITE4TB Clinical trial preparations in Vietnam
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-09-19 12:21:022023-04-20 10:39:3219/09/22 – UNITE4TB Exploring synergies and collaborations
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-09-19 12:20:082023-04-20 10:40:2219/09/22 – The UNITE4TB Community Advisory Group: Voice of the TB community
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-09-19 12:19:262023-04-20 10:31:1019/09/22 – Year-1 highlights from the UNITE4TB project leads
https://amr-accelerator.eu/wp-content/uploads/2021/12/TRiC_TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-06-21 15:12:252022-06-21 15:12:2521/06/22 – BioVersys successfully completes Phase I clinical trials of BVL-GSK098
08/06/22 – Positive results for preclinical development of the first-in-class antibiotics NOSO-502
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2022-05-18 08:00:222023-04-20 10:35:5218/05/22 – UNITE4TB 2022 Annual Meeting